483 Catalent Maryland Nov 2021

483 Catalent Maryland Nov 2021

Debra Emerson FDA, Claire Minden FDA$595.00 - Available Now

FDA investigators audited the Catalent Maryland - Harmans, MD, United States facility and issued inspectional observations (via FDA 483) on 17 Nov 2021.

Product details

  • Category: Biologics
  • Inspection end: 17 Nov 2021
  • Location: Harmans, United States
  • FEI: 3015434301
Add To Cart